Literature DB >> 15389495

Novel fabricated matrix via electrospinning for tissue engineering.

Myung-Seob Khil1, Shanta Raj Bhattarai, Hak-Yong Kim, Sung-Zoo Kim, Keun-Hyung Lee.   

Abstract

Electric field-driven fiber formation (electrospinning) is developing into a practical means for preparing novel porous filament with unusual structures and affordable mechanical properties. Polycaprolactone (PCL) was dissolved in solvent mixtures of methylene chloride/N,N-dimethyl formamide with ratios of 100/0, 75/25, and 50/50 (v/v) for electrospinning. The filament was formed by coagulation of the spinning solution following the well-known principle of phase separation in polymer solutions valid in other wet shaping processes. A strand of electrospun porous filament consisted of fibers ranging from 0.5 to 12 microm in diameter. To evaluate the feasibility of three-dimensional fabric as scaffold matrices, the plain weave, which is the simplest of the weaves and the most common, was prepared with porous PCL filament. The growth characteristics of MCF-7 mammary carcinoma cells in the woven fabrics showed the important role of matrix microstructure in proliferation. This study has shown that woven fabrics, consisting of porous filaments via electrospinning, may be suitable candidates as tissue engineering scaffolds. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15389495     DOI: 10.1002/jbm.b.30122

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  26 in total

1.  Electro-spinning of PLGA/PCL blends for tissue engineering and their biocompatibility.

Authors:  Nguyen Thi Hiep; Byong-Taek Lee
Journal:  J Mater Sci Mater Med       Date:  2010-03-16       Impact factor: 3.896

Review 2.  The role of electrospinning in the emerging field of nanomedicine.

Authors:  S Y Chew; Y Wen; Y Dzenis; K W Leong
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 3.  Functional electrospun nanofibrous scaffolds for biomedical applications.

Authors:  Dehai Liang; Benjamin S Hsiao; Benjamin Chu
Journal:  Adv Drug Deliv Rev       Date:  2007-08-25       Impact factor: 15.470

Review 4.  Technological advances in electrospinning of nanofibers.

Authors:  Wee-Eong Teo; Ryuji Inai; Seeram Ramakrishna
Journal:  Sci Technol Adv Mater       Date:  2011-01-12       Impact factor: 8.090

5.  Multilayered electrospun scaffolds for tendon tissue engineering.

Authors:  Abby Chainani; Kirk J Hippensteel; Alysha Kishan; N William Garrigues; David S Ruch; Farshid Guilak; Dianne Little
Journal:  Tissue Eng Part A       Date:  2013-08-29       Impact factor: 3.845

6.  The effect of cross-linking on the microstructure, mechanical properties and biocompatibility of electrospun polycaprolactone-gelatin/PLGA-gelatin/PLGA-chitosan hybrid composite.

Authors:  Thi-Hiep Nguyen; Byong-Taek Lee
Journal:  Sci Technol Adv Mater       Date:  2012-06-13       Impact factor: 8.090

7.  bFGF-containing electrospun gelatin scaffolds with controlled nano-architectural features for directed angiogenesis.

Authors:  Ramon B Montero; Ximena Vial; Dat Tat Nguyen; Sepehr Farhand; Mark Reardon; Si M Pham; Gavriil Tsechpenakis; Fotios M Andreopoulos
Journal:  Acta Biomater       Date:  2011-12-13       Impact factor: 8.947

8.  Electrospun fibrous scaffolds promote breast cancer cell alignment and epithelial-mesenchymal transition.

Authors:  Sharmistha Saha; Xinrui Duan; Laying Wu; Pang-Kuo Lo; Hexin Chen; Qian Wang
Journal:  Langmuir       Date:  2011-12-27       Impact factor: 3.882

9.  Modulation of embryonic mesenchymal progenitor cell differentiation via control over pure mechanical modulus in electrospun nanofibers.

Authors:  Jin Nam; Jed Johnson; John J Lannutti; Sudha Agarwal
Journal:  Acta Biomater       Date:  2010-11-22       Impact factor: 8.947

10.  Current Status of Tissue-Engineered Scaffolds for Rotator Cuff Repair.

Authors:  Abby Chainani; Dianne Little
Journal:  Tech Orthop       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.